kaf

Conclusion KAF can inhibit telomerase activity of human colon cancer cells .

结论KAF能抑制人结肠癌细胞端粒酶活性。

Proof-of-concept data are expected soon on a second Novartis compound , known as KAF 156 .

预计诺华的第二种复方药物（名为KAF156）的概念验证数据将很快出炉。

The positive early data must be replicated in larger studies if KAE 609 and KAF 156 are to satisfy regulators .

要让KAE609和KAF156获得监管机构的批准，积极的早期数据必须在更大规模的研究中得到验证。

It could be deduced that some large molecule substances could activate CR1 and C3b fragments , and the KAF might play important role in modulating red blood cell immune function .

推测某些大分子物质能激活CR1，中小分子量血浆物质中C3b片段和C3b灭活因子（KAF）在调节红细胞免疫粘附功能中起着重要作用。

Unlike artemisinin-based therapies , KAF 156 acts against the parasites while still in the asymptomatic " liver stage " of the disease , before it has spread into the blood stream .

与基于青蒿素的疗法不同，KAF156可以在疟疾的无症状“肝脏期”、在疾病蔓延到血流之前杀灭寄生虫。